Zdrowie i gospodarka · 29/04/2024

FDA Clears FLUDARABINE PHOSPHATE Injection for Sale

The US Food and Drug Administration (FDA) has determined that FLUDARABINE PHOSPHATE Injection, 50 mg/2 mL, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market and continue to be approved for use in abbreviated new drug applications (ANDAs) that meet regulatory requirements.